| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |